Posts in COVID-19
F103 How are smart garments making remote patient monitoring comfortable? (Laurent Vandebrouck, Chronolife)

Chronolife is a French company innovating in the space of smart garments for remote patient monitoring. Clothes are not the main innovation of the company, their secret sauce is a patented neuromorphic (bio-mimetic) algorithm, HOTS (Hierarchy Of event-based Time-Surfaces). The algorithm detects and predicts deterioration in patients’ state of health and alerts caregivers to allow earlier intervention and avoid costly hospitalizations.

Read More
F096 Why can we be optimistic about the vaccine development for COVID-19? (Glen de Vries, Medidata)

Data gathering is not a problem in COVID-19 race towards a reliable vaccine. The challenge is how to evaluate it, says Glen de Vries, Co-Founder and Co-CEO of Medidata. End of July Medidata started working with Moderna to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

Read More
F072 DTx series 1/5: How do DTx differ from medications or digital health apps? (Jessica Shull)

Digital therapeutics (DTx) are clinically validated digital solutions with proven positive effects on disease management and outcomes. They must undergo a clinical trial to prove their efficacy, however, they are not regulated the same as new medications, says Jessica Schull, European Lead for the Digital Therapeutics Alliance (DTA), shaping advocacy and organizational engagement for the DTx industry in European countries.

Read More
F071 Why is St. Louis a hidden digital health ecosystem gem in the US and the latest about digital health efforts for COVID-19

When Europe became the new epicentre of the Covid-19 spread, and with the steady rise of infected in the US, tech companies offered their knowledge to curb the pandemic: from Covid-19 apps, the rise of telemedicine use in the US, 3D printing in Italy and more efforts to curb the Coronavirus crisis.

Read More